EPIGENETIC SIGNATURES OF ANXIETY DISORDERS AND OCD: FROM MOLECULAR INSIGHTS TO CLINICAL TRANSLATION

Overall Abstract Anxiety disorders, such as generalized anxiety disorder, panic disorder, and phobias, as well as obsessive compulsive disorder (OCD) are highly prevalent mental disorders that impose significant socioeconomic and personal burdens. Epigenetic mechanisms, particularly DNA methylation, are of interest as a correlate of anxiety disorders because of their role in adapting to the environment throughout the life course and their potential as predictors of treatment response. At the same time, several aspects need to be considered in epigenome-wide association studies of anxiety disorders, including disentangling anxiety and depression signatures, epigenetic signatures across the life span, sample size, and the translational potential of the results. This symposium will present recent findings from members of the PGC Anxiety Epigenetics Working Groups and discuss current topics in the epigenetics of anxiety disorders and OCD. In the first presentation, Daniel Levey will examine epigenetic signatures of anxiety and depression in the Million Veteran Program. The second talk by Colter Mitchell will focus on structured life-course EWAS of internalizing behaviors and anxiety from early childhood into young adulthood. In the third presentation, Lea Zillich will present the latest results of the groups’ cross-anxiety meta-analysis, identifying DNA methylation signatures across nine clinical cohorts and more than 3,000 participants. The fourth talk from Kira Höffler will focus on DNA methylation as a therapeutic marker in OCD. Finally, Thalia Eley will serve as discussant, synthesizing the key findings of the presentations and providing perspectives on potential clinical applications of epigenetic research in anxiety disorders and OCD. Together, these presentations will provide an overview of the current advances in psychiatric epigenetics of anxiety disorders and OCD and discuss future directions to better understand disease mechanisms and improve prediction and prevention strategies.

Authors

Institutions

Publication Details

Journal
European Neuropsychopharmacology
Published
2026-09-21
DOI
https://doi.org/10.1016/j.euroneuro.2026.112991
Primary Topic
Epigenetics and DNA Methylation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

EPIGENETIC SIGNATURES OF ANXIETY DISORDERS AND OCD: FROM MOLECULAR INSIGHTS TO CLINICAL TRANSLATION

Lea Zillich, Thalia Eley, Shaunna Clark
European Neuropsychopharmacology
Epigenetics and DNA Methylation
article

EPIGENETIC SIGNATURES OF ANXIETY DISORDERS AND OCD: FROM MOLECULAR INSIGHTS TO CLINICAL TRANSLATION

Lea Zillich, Thalia Eley, Shaunna Clark
article en

Abstract

Overall Abstract Anxiety disorders, such as generalized anxiety disorder, panic disorder, and phobias, as well as obsessive compulsive disorder (OCD) are highly prevalent mental disorders that impose significant socioeconomic and personal burdens. Epigenetic mechanisms, particularly DNA methylation, are of interest as a correlate of anxiety disorders because of their role in adapting to the environment throughout the life course and their potential as predictors of treatment response. At the same time, several aspects need to be considered in epigenome-wide association studies of anxiety disorders, including disentangling anxiety and depression signatures, epigenetic signatures across the life span, sample size, and the translational potential of the results. This symposium will present recent findings from members of the PGC Anxiety Epigenetics Working Groups and discuss current topics in the epigenetics of anxiety disorders and OCD. In the first presentation, Daniel Levey will examine epigenetic signatures of anxiety and depression in the Million Veteran Program. The second talk by Colter Mitchell will focus on structured life-course EWAS of internalizing behaviors and anxiety from early childhood into young adulthood. In the third presentation, Lea Zillich will present the latest results of the groups’ cross-anxiety meta-analysis, identifying DNA methylation signatures across nine clinical cohorts and more than 3,000 participants. The fourth talk from Kira Höffler will focus on DNA methylation as a therapeutic marker in OCD. Finally, Thalia Eley will serve as discussant, synthesizing the key findings of the presentations and providing perspectives on potential clinical applications of epigenetic research in anxiety disorders and OCD. Together, these presentations will provide an overview of the current advances in psychiatric epigenetics of anxiety disorders and OCD and discuss future directions to better understand disease mechanisms and improve prediction and prevention strategies.

European NeuropsychopharmacologyVol. 111
King's College London (GB), University Medical Center Freiburg (DE), Mitchell Institute (US)
Openalex Percentile: Top 18%
Epigenetics and DNA Methylation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.